~~<i id='0CB101882F'><strike id='0CB101882F'><tt id='0CB101882F'><pre id='0CB101882F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

Wikipedia

author：explore 2025-09-06 02:15:32 - browse：691

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： The leaders of Italy and Poland say European Union should focus on stopping migration

hotspot

leisure time

knowledge

hotspot

2:45PeoplestandbyrubbleandtheremainsofadestroyedvehicleoutsideamosqueintheoccupiedWestBankcityofJeni

WSS

ER docs worry over extreme heat as a 'mass casualty event'

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Pope Francis asks Church to identify 21st

Lack of darker skin in textbooks, journals harms patients of color

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

entertainment

Wikipedia

hotspot

Jerome Adams on the need for new antivirals for Covid

Robert Kennedy Jr.'s presidential campaign attracts GOP

In age of alternative facts, a scholarly course on calling out crap

BridgeBio heart drug succeeds in pivotal study

Novavax promises a turnaround & Lilly roils the obesity market

FDA seeking to stop procedures at two unregulated stem cell clinics

Psychedelics group wrestles with new pharma identity

Biden administration sends mixed signals on US soldier who crossed into North Korea

Psychedelics group wrestles with new pharma identity

US soldier in North Korean custody after crossing DMZ line

hotspot

15 die by electrocution after transformer explodes in northern India

Study: Hearing aids may slow cognitive decline in those at risk

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Robert Kennedy Jr.'s presidential campaign attracts GOP

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

House passes resolution saying Israel isn't a 'racist or apartheid state'

leisure time

leisure time

knowledge

hotspot